Twitter

Facebook

Youtube

RSS

Hindi News | Samay | UP/Uttarakhand | MP/Chhattisgarh | Bihar/Jharkhand | Rajasthan | Aalami Samay
  Rashtriya Sahara Roznama Sahara
Serum Institute's Covovax approved for kids aged 7 to 11 years
IANS
New Delhi
Last Updated : 28 Jun 2022 11:12:40 PM IST

 

India's apex drugs regulator, the Drugs Controller General of India (DCGI), on Tuesday approved Pune-based Serum Institute's Covid vaccine Covovax for children aged 7 to 11 years, as per a source.

The source said that SII's Covovax vaccine has been approved for restricted emergency use in children aged 7 to 11 years subject with certain conditions.
 
On June 24, the DCGI's Subject Expert Committee had recommended emergency use authorisation to Covovax vaccine for use in children aged 7-11.
 
As per the source, the DCGI has also approved India's first indigenously developed mRNA vaccine against Covid-19 manufactured by Gennova Biopharmaceuticals for restricted emergency use for those aged 18 years and above.
 
The DCGI had approved Covovax for restricted use in emergency situations in adults on December 28 and in the 12 to 17 years age group, subject to certain conditions, on March 9.
 


For Latest Updates Please-

Join us on

Follow us on

Post Your Comment (0 posted):
Post your comment Post Your Comments
Your name :
Your e-mail address :
Your website :
Add your comments :
Please enter the code you see in the image:
Code

What binds the two most talked about nations - India and Pakistan together? What makes the

Actor Dhanush, who was most recently seen in the Tamil movie 'Naane Varuvean' and has beco

LG Electronics Inc said on Wednesday that it will introduce new C with its artificial inte

 

Samay Live
Samay Live
Samay Live
Samay Live
Samay Live
Samay Live
Samay Live
Samay Live

172.31.16.186